FoRx Therapeutics

Founded 2020 · $61.7M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$61.7M
Last Round
$50.0M Series ADec 2025
Rounds
2

About

FoRx Therapeutics is a privately held clinical-stage biotechnology company pioneering precision therapeutics that exploit DNA Replication Stress (DRS) as a vulnerability in treatment-resistant cancers. The company is developing oral small molecule drugs, including its lead PARG inhibitor FORX-428, targeting oncology indications where conventional therapies have failed. FoRx focuses on translating the biology of replication stress into best-in-class clinical candidates with a differentiated mechanism of action.

Summary

FoRx Therapeutics is a Biotech company, founded in 2020. It has raised $61.7M in total across 2 rounds, most recently a $50.0M Series A round in Dec 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ADec 2025
$50.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

FoRx Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/forx-therapeutics"><img src="https://indexed.vc/api/badge/company/forx-therapeutics" alt="FoRx Therapeutics on Indexed.vc" width="260" height="76" /></a>